Evercore ISI lowered the firm’s price target on Fortrea Holdings (FTRE) to $30 from $31 and keeps an In Line rating on the shares ahead of Q3 earnings from the healthcare tech and distribution group. In the group, the firm’s top picks include CVS Health (CVS), its top large cap pick, Iqvia (IQV) and R1 RCM (RCM), the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on FTRE:
- Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference Call
- Fortrea’s Jim Cameli Named a Top 100 Global Chief Information Security Officer by HotTopics
- Fortrea Holdings initiated with an In Line at Evercore ISI
- Fortrea to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
- Fortrea to Present at the Baird 2023 Global Healthcare Conference